Myosin Therapeutics Inc.

Myosin Therapeutics Inc.

Private
Jupiter, FloridaHealthcare & Life Scienceshttps://myosintherapeutics.com

Last Round

Grant

Mar 24, 2026

Total Funding Raised

$12.5M

Momentum Score

50 /100

Company Overview

Myosin Therapeutics Inc. is a biotechnology company that develops novel pharmacotherapies targeting members of the myosin family of molecular motors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

myosin inhibitorsmall molecule drugsglioblastoma therapyNMII inhibitormethamphetamine addictiondrug discovery platformclinical-stage biotechfirst-in-class drugmotor protein therapeuticsoncology drug developmentCNS disorder therapytumor invasion inhibitorInvestigational New DrugINDSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myosin Therapeutics Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Myosin Therapeutics Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMar 24, 2026
GrantAug 19, 2025
GrantApr 28, 2025
SeedMar 4, 2025
SeedMar 14, 2023

Myosin Therapeutics Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2026

    $2M raised in grant funding.

  • Jan 29, 2026

    Invited to present at Biocom California's Global Partnering & Investor Conference.

Myosin Therapeutics Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Myosin Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myosin Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJupiter, Florida
Employee Range9
Year Founded2020
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.